Your Psychology Psychology articles and news

Researchers reported results from the first repeated-dose study of a dopamine-1 receptor (D1R) agonist for treating the cognitive and negative symptoms of schizophrenia yesterday in the Journal of…

A new University of British Columbia study shows that genetic counselling helps patients with schizophrenia, bipolar disorder and similar conditions understand and cope with their illness.

The term “schizophrenia,” with its connotation of hopeless chronic brain disease, should be dropped and replaced with something like “psychosis spectrum syndrome,” argues a professor of psychiatry…

A landmark study, based on genetic analysis of nearly 65,000 people, has revealed that a person’s risk of schizophrenia is increased if they inherit specific variants in a gene related to “synaptic…

Numerous genetic variants associated with risk for schizophrenia have been identified. However, little is known about how these genes have their effects in the brain.

Mounting evidence indicates that disturbances in the brain’s glutamate pathway contribute to symptoms of schizophrenia.

In a groundbreaking study led by UT Southwestern Medical Center, a comprehensive set of empirical biomarkers has been established to aid in diagnosis and treatment of psychosis.

New research published online today in the British Journal of Psychiatry, suggests an association between the loss of brain grey matter tissue and the development of negative symptoms in people…

New analysis links cognitive, emotional, and intellectual symptoms to neurological ‘disruption’ in multiple brain regions – a finding with important implications for diagnosis and treatment.

Research on the comparative effectiveness of antipsychotic medications.In real-world settings, patients with schizophrenia whose symptoms do not respond to standard antipsychotic medications have…